Clinical Trials List
2016-07-30 - 2025-05-13
Phase II
Terminated5
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chi-Lu Chiang 無
- 張毓帆 無
- Hsu-ching Huang 無
- Chueh-Chuan Yen 無
- Chia-I Shen 無
- 郭懿萱 無
- 趙恒勝 無
- Chao-Hua Chiu 無
- Yi-Jen Chen 無
- 蔡俊明 無
- Yi-Ping Hung 無
- Ming-Huang Chen 無
- 蕭慈慧 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chong-Jen Yu 無
- 許嘉林 無
- Kun-Huei Yeh 無
- Jih-Hsiang Lee 無
- Wei-Wu Chen 無
- 廖唯昱 無
- JIN-YUAN SHIH 無
- 陳國興 無
- 廖斌志 無
- CHAO-CHI HO CHAO-CHI HO 無
- 徐偉勛 無
- James Chih-Hsin Yang 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yin Wu 無
- Wei-Pang Chung 無
- Sin-Syue Li 無
- Chia-Jui Yen 無
- Yu-Min Yeh 無
- Wu-Chou Su 無
- Wen-Pin Su 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
600 participants
